{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:20:30Z","timestamp":1773868830624,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T00:00:00Z","timestamp":1241568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00415-009-5160-0","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T07:56:39Z","timestamp":1241510199000},"page":"1540-1550","source":"Crossref","is-referenced-by-count":43,"title":["Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients"],"prefix":"10.1007","volume":"256","author":[{"given":"In\u00eas Esteves","family":"Baldeiras","sequence":"first","affiliation":[]},{"given":"Maria Helena","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Pacheco","sequence":"additional","affiliation":[]},{"given":"\u00c1lvaro","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Santana","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Catarina Resende","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,5,6]]},"reference":[{"key":"5160_CR1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(94)90691-2","volume":"344","author":"P Amouyel","year":"1994","unstructured":"Amouyel P, Vidal O, Launay JM, Laplanche JL (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt\u2013Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 344:1315\u20131318. doi: 10.1016\/S0140-6736(94)90691-2","journal-title":"Lancet"},{"key":"5160_CR2","first-page":"1147","volume":"16","author":"K Blennow","year":"2005","unstructured":"Blennow K, Johansson A, Zetterberg H (2005) Diagnostic value of 14-3-3\u03b2 immunoblot and T-tau\/P-tau ratio in clinically suspected Cretzfeldt\u2013Jakob disease. Int J Mol Med 16:1147\u20131149","journal-title":"Int J Mol Med"},{"key":"5160_CR3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2005.06.056","volume":"388","author":"P Bosco","year":"2005","unstructured":"Bosco P, Gu\u00e9ant-Rodriguez RM, Anello G, Spada RS, Romano A, Caraci F, Ferri R, Gu\u00e9ant JL (2005) Allele epsilon 4 of ApoE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Neurosci Lett 388:168\u2013172","journal-title":"Neurosci Lett"},{"key":"5160_CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.1995.tb00625.x","volume":"5","author":"H Budka","year":"1995","unstructured":"Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Kl Jellinger (1995) Neuropathological diagnostic criteria for Creutzfeldt\u2013Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5:459\u2013466. doi: 10.1111\/j.1750-3639.1995.tb00625.x","journal-title":"Brain Pathol"},{"key":"5160_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2004.12.003","volume":"27","author":"K Buerger","year":"2006","unstructured":"Buerger K, Otto M, Teiperl SJ, Zinkowski R, Blennow K, DeBernardis J, Kerkman D, Schr\u00f6eder J, Sch\u00f6nknecht P, Cepek L, McCulloch C, M\u00f6ller HJ, Wiltfang J, Kretzschmar H, Hampel H (2006) Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt\u2013Jakob disease. Neurobiol Aging 27:10\u201315. doi: 10.1016\/j.neurobiolaging.2004.12.003","journal-title":"Neurobiol Aging"},{"key":"5160_CR6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1212\/WNL.56.11.1528","volume":"56","author":"PR Burkhard","year":"2001","unstructured":"Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF (2001) CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology 56:1528\u20131533","journal-title":"Neurology"},{"key":"5160_CR7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.55.9.1396","volume":"55","author":"T Chapman","year":"2000","unstructured":"Chapman T, McKeel DW Jr, Morris JC (2000) Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 55:1396\u20131397","journal-title":"Neurology"},{"key":"5160_CR8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/crad.2001.0771","volume":"56","author":"DA Collie","year":"2001","unstructured":"Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG (2001) MRI of Creutzfeldt\u2013Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 56:726\u2013739. doi: 10.1053\/crad.2001.0771","journal-title":"Clin Radiol"},{"key":"5160_CR9","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","volume":"129","author":"SJ Collins","year":"2006","unstructured":"Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alp\u00e9rovitch A, Brandel JP, Mackenzie J, Murray K, Will RG (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt\u2013Jakob disease. Brain 129:2278\u20132287. doi: 10.1093\/brain\/awl159","journal-title":"Brain"},{"key":"5160_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0270(94)90168-6","volume":"53","author":"R Crook","year":"1994","unstructured":"Crook R, Hardy J, Duff K (1994) Single-day apolipoprotein E genotyping. J Neurosci Methods 53:125\u2013127. doi: 10.1016\/0165-0270(94)90168-6","journal-title":"J Neurosci Methods"},{"key":"5160_CR11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","volume":"60","author":"MD Geschwind","year":"2003","unstructured":"Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL (2003) Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt\u2013Jakob disease. Arch Neurol 60:813\u2013816. doi: 10.1001\/archneur.60.6.813","journal-title":"Arch Neurol"},{"key":"5160_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jnnp.2005.065755","volume":"77","author":"CA Goodall","year":"2006","unstructured":"Goodall CA, Head MW, Everington D, Ironside JW, Knight RSG, Green AJE (2006) Raised CSF phospho-tau concentrations in variant Creutzfeldt\u2013Jakob disease: diagnostic and pathological implications. J Neurol Neurosurg Psychiatry 77:89\u201391. doi: 10.1136\/jnnp.2005.065755","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5160_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(02)00172-6","volume":"324","author":"AJ Green","year":"2002","unstructured":"Green AJ, Ramljak S, Muller WE, Knoght RS, Schroeder HC (2002) 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt\u2013Jakob disease measured using a capture assay able to detect low levels of 14-3-3 protein. Neurosci Lett 324:57\u201360. doi: 10.1016\/S0304-3940(02)00172-6","journal-title":"Neurosci Lett"},{"key":"5160_CR14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.70.6.744","volume":"70","author":"AJ Green","year":"2001","unstructured":"Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will JG, Knight RS (2001) Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt\u2013Jakob disease. J Neurol Neurosurg Psychiatry 70:744\u2013748. doi: 10.1136\/jnnp.70.6.744","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5160_CR15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","volume":"126","author":"AF Hill","year":"2003","unstructured":"Hill AF, Joiner S, Wadsworth JDF, Sidle KCL, Bell JE, Budka H, Ironside JW, Collinge J (2003) Molecular classification of sporadic Creutzfeldt\u2013Jakob disease. Brain 126:1333\u20131346. doi: 10.1093\/brain\/awg125","journal-title":"Brain"},{"key":"5160_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2000.00946.x","volume":"37","author":"JW Ironside","year":"2000","unstructured":"Ironside JW, Head MW, Bell JE, McCardle L, Will RG (2000) Laboratory diagnosis of variant Creutzfeldt\u2013Jakob disease. Histopathology 37:1\u20139. doi: 10.1046\/j.1365-2559.2000.00946.x","journal-title":"Histopathology"},{"key":"5160_CR17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","volume":"71","author":"E Kapaki","year":"2001","unstructured":"Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E (2001) Highly increased CSF tau protein and decreased \u03b2-amyloid (1\u201342) in sporadic CJD: a discrimination from Alzheimer\u2019s disease? J Neurol Neurosurg Psychiatry 71:401\u2013403. doi: 10.1136\/jnnp.71.3.401","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5160_CR18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A","volume":"48","author":"K Kenney","year":"2000","unstructured":"Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ Jr (2000) An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt\u2013Jakob disease. Ann Neurol 48:395\u2013398. doi: 10.1002\/1531-8249(200009)48:3<395::AID-ANA18>3.0.CO;2-A","journal-title":"Ann Neurol"},{"key":"5160_CR19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.55.4.514","volume":"55","author":"AW Lemstra","year":"2000","unstructured":"Lemstra AW, van Meegen MT, Vreyling JP, Meijering PH, Jansen GH, Bulk S, Baas F, van Gool WA (2000) 14-3-3 testing in diagnosing Creutzfeldt\u2013Jakob disease: a prospective study in 112 patients. Neurology 55:514\u2013516","journal-title":"Neurology"},{"key":"5160_CR20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3940(95)11366-5","volume":"187","author":"Y Nakagawa","year":"1995","unstructured":"Nakagawa Y, Kitamoto T, Furukawa H, Ogomori K, Tateishi J (1995) Alelic variatic of apolipoprotein E in Japanese sporadic Creutzfeldt\u2013Jakob disease patients. Neurosci Lett 187:209\u2013211. doi: 10.1016\/0304-3940(95)11366-5","journal-title":"Neurosci Lett"},{"key":"5160_CR21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s004150050145","volume":"244","author":"M Otto","year":"1997","unstructured":"Otto M, Stein H, Szudra A, Zerr I, Bodemer M, Gefeller O, Poser S, Kretzschmar HA, M\u00e4der M, Weber T (1997) S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease. J Neurol 244:566\u2013570. doi: 10.1007\/s004150050145","journal-title":"J Neurol"},{"key":"5160_CR22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 58:192\u2013197","journal-title":"Neurology"},{"key":"5160_CR23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.b.20146","volume":"126","author":"F Panza","year":"2004","unstructured":"Panza F, D\u00edntrono A, Colacicco AM, Capruso C, Basile AM, Capurso S, Capurso A, Solfrizzi V (2004) Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet 126:69\u201373. doi: 10.1002\/ajmg.b.20146","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5160_CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt\u2013Jakob disease based on molecular and phenotypic analysis of 300 patients. Ann Neurol 46:224\u2013233. doi: 10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","journal-title":"Ann Neurol"},{"key":"5160_CR25","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/brain\/awh249","volume":"127","author":"M Pocchiari","year":"2004","unstructured":"Pocchiari M, Poupolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar HA, Ladogana A, Rietvald I, Mitrova E, Martinez-Martin P, de Pedro-Cuesta J, Glatzel M, Aguzzi A, Cooper S, Mackenzie J, van Duijn CM, Will RG (2004) Predictors of survival in sporadic Creutzfeldt\u2013Jakob disease and other human transmissible spongiform encephalopathies. Brain 127:2348\u20132359. doi: 10.1093\/brain\/awh249","journal-title":"Brain"},{"key":"5160_CR26","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/brain\/122.12.2345","volume":"12","author":"S Poser","year":"1999","unstructured":"Poser S, Mollenhauer B, Kraubeta A, Zerr I, Steinhoff BJ, Schroeter A, Finkenstaedt M, Schulz-Schaeffer WJ, Kretzschmar HA, Felgenhauer K (1999) How to improve the clinical diagnosis of Creutzfeldt\u2013Jakob disease. Brain 12:2345\u20132351. doi: 10.1093\/brain\/122.12.2345","journal-title":"Brain"},{"key":"5160_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410350404","volume":"35","author":"SB Prusiner","year":"1994","unstructured":"Prusiner SB, Hsiao KK (1994) Human prion diseases. Ann Neurol 35:385\u2013395. doi: 10.1002\/ana.410350404","journal-title":"Ann Neurol"},{"key":"5160_CR28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","volume":"8","author":"M Riemenschneider","year":"2003","unstructured":"Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, F\u00f6rstl H, Kurz A (2003) Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt\u2013Jakob disease from other dementias. Mol Psychiatry 8:343\u2013347. doi: 10.1038\/sj.mp.4001220","journal-title":"Mol Psychiatry"},{"key":"5160_CR29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(95)12030-8","volume":"199","author":"M Salvatore","year":"1995","unstructured":"Salvatore M, Seeber AC, Nacmias B, Petraroli R, D\u00e1lessandro M, Sorbi S, Pocchiari M (1995) Apolipoprotein E in sporadic and familial Creutzfekdt\u2013Jakob disease. Neurosci Lett 199:95\u201398. doi: 10.1016\/0304-3940(95)12030-8","journal-title":"Neurosci Lett"},{"key":"5160_CR30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, S\u00e1anchez-Valle R, Mitrov\u00e1a E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichov\u00e1 D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I (2006) CSF tests in the differential diagnosis of Creutzfeldt\u2013Jakob disease. Neurology 67:637\u2013643. doi: 10.1212\/01.wnl.0000230159.67128.00","journal-title":"Neurology"},{"key":"5160_CR31","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrov\u00e1 E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichov\u00e1 D, Saiz A, Calero M, Pocchiari M, Knight R, van Dujin C, Zerr I (2007) Influence of timing on CSF tests value for Cretzfeldt\u2013Jakob disease diagnosis. J Neurol 254:901\u2013906. doi: 10.1007\/s00415-006-0472-9","journal-title":"J Neurol"},{"key":"5160_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10571-006-9370-z","volume":"26","author":"K Satoh","year":"1995","unstructured":"Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H (1995) 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt\u2013Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 26:45\u201352. doi: 10.1007\/s10571-006-9370-z","journal-title":"Cell Mol Neurobiol"},{"key":"5160_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000107082","volume":"24","author":"K Satoh","year":"2007","unstructured":"Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K (2007) Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt\u2013Jakob disease. Dement Geriatr Cogn Disord 24:207\u2013212. doi: 10.1159\/000107082","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5160_CR34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ana.20261","volume":"56","author":"BJ Steinhoff","year":"2004","unstructured":"Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA (2004) Diagnostic value of periodic complexes in Creutzfeldt\u2013Jakob disease. Ann Neurol 56:702\u2013708. doi: 10.1002\/ana.20261","journal-title":"Ann Neurol"},{"key":"5160_CR35","doi-asserted-by":"crossref","first-page":"e1000029","DOI":"10.1371\/journal.ppat.1000029","volume":"4","author":"E Uro-Coste","year":"2008","unstructured":"Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A, Ironside JW, Haik S, Basset-Leobon C, Lacroux C, Peoch K, Streichenberger N, Langeveld J, Head MW, Grassi J, Hauw JJ, Schelcher F, Delisle MB, Andr\u00e9oletti O (2008) Beyond PrPres type 1\/type 2 dichotomy in Creutzfeldt\u2013Jakob disease. PLoS Pathog 4:e1000029. doi: 10.1371\/journal.ppat.1000029","journal-title":"PLoS Pathog"},{"key":"5160_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clineuro.2004.12.002","volume":"107","author":"B Everbroeck Van","year":"2005","unstructured":"Van Everbroeck B, Boons J, Cras P (2005) Cerebrospinal fluid biomarkers in Creutzfeldt\u2013Jakob disease. Clin Neurol Neurosurg 107:355\u2013360. doi: 10.1016\/j.clineuro.2004.12.002","journal-title":"Clin Neurol Neurosurg"},{"key":"5160_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)02264-9","volume":"313","author":"B Everbroeck Van","year":"2001","unstructured":"Van Everbroeck B, Croses EA, Pals P, Dermaut B, Jansen G, van Dujin CM, Cruts M, van Broeckhoven C, Martin JJ, Cras P (2001) Influence of the prion protein and the apolipoprotein E genotype on the Creutzfelt\u2013Jakob disease phenotype. Neurosci Lett 313:69\u201372. doi: 10.1016\/S0304-3940(01)02264-9","journal-title":"Neurosci Lett"},{"key":"5160_CR38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jnnp.73.1.79","volume":"73","author":"B Everbroeck Van","year":"2002","unstructured":"Van Everbroeck B, Green AJE, Vanmechelen E, Vanderstichele H, Pals P, Sanchez-Valle R, Cuadrado Corrales N, Martin JJ, Cras P (2002) Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 73:79\u201382. doi: 10.1136\/jnnp.73.1.79","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5160_CR39","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","volume":"74","author":"B Everbroeck Van","year":"2003","unstructured":"Van Everbroeck B, Quoilin S, Boons J, Martin JJ, Cras P (2003) A prospective study of CSF markers in 250 patients with possible Creutzfeldt\u2013Jakob disease. J Neurol Neurosurg Psychiatry 74:1210\u20131214. doi: 10.1136\/jnnp.74.9.1210","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5160_CR40","first-page":"249","volume":"19","author":"T Weber","year":"2000","unstructured":"Weber T (2000) Clinical and laboratory diagnosis of Creutzfeldt\u2013Jakob disease. Clin Neuropathol 19:249\u2013250","journal-title":"Clin Neuropathol"},{"key":"5160_CR41","unstructured":"World Health Organization. Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. WHO, Geneva, 8\u201311 February 1998"},{"key":"5160_CR42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt\u2013Jakob disease. Ann Neurol 43:32\u201340. doi: 10.1002\/ana.410430109","journal-title":"Ann Neurol"},{"key":"5160_CR43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(95)90118-3","volume":"345","author":"I Zerr","year":"1995","unstructured":"Zerr I, Bodemer M, R\u00e4cker S, Grosche S, Poser S, Kretzschmar HA, Weber T (1995) Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt\u2013Jakob disease. Lancet 345:1609\u20131610. doi: 10.1016\/S0140-6736(95)90118-3","journal-title":"Lancet"},{"key":"5160_CR44","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.1996.00550120041014","volume":"53","author":"I Zerr","year":"1996","unstructured":"Zerr I, Helmhold M, Poser S, Armstrong VW, Weber T (1996) Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt\u2013Jakob disease. Arch Neurol 53:1233\u20131238","journal-title":"Arch Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5160-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5160-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:12:50Z","timestamp":1559070770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5160-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,6]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["5160"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5160-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,6]]}}}